Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine plus tacrolimus and glucocorticoid for idiopathic membranous nephropathy
ChiCTR2200067000Phase 4Not yet recruiting
- Sponsor
- The Seventh Affiliated Hospital, Sun Yat-Sen University
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in idiopathic membranous glomerulonephritis (IMG) comparing Hydroxychloroquine arm with Placebo arm (2 arms). Primary endpoints: Complete remission rate and Partial remission rate. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
idiopathic membranous glomerulonephritis (IMG)
Beyond the preview
Go deeper on ChiCTR2200067000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200067000.